New Emergent Ventures anti-Covid prize winners

The first new prize is to Anup Malani of the University of Chicago, with his team, for their serological research in India and Mumbia.  They showed rates of 57 percent seroprevalance in the Mumbai slums, a critical piece of information for future India policymaking.  Here is the research.

Professor Malani is now working in conjunction with Development Data Lab to extend the results by studying other parts of India.

The second new prize goes to 1Day Sooner, a 2020-initiated non-profit which has promoted the idea of Human Challenge Trials for vaccines and other biomedical treatments.  Alex here covers the pending HCTs in Britain, as well as providing links to previous MR coverage of the topic.

I am delighted to have them both as Emergent Ventures prize winners.

Here are the first, second, and third cohorts of winners of Emergent Ventures prizes against Covid-19.


Comments for this post are closed